Sponsors flock to new opportunities in pharma services
Companies providing services to drug-makers are particularly hot. Sales of recent assets have commanded EBITDA multiples in the mid-teens to 20x.
Companies providing services to drug-makers are particularly hot. Sales of recent assets have commanded EBITDA multiples in the mid-teens to 20x.
Copyright PEI Media
Not for publication, email or dissemination